2003
DOI: 10.1038/sj.bmt.1704338
|View full text |Cite
|
Sign up to set email alerts
|

Gram-negative bacteraemia (GNB) after 428 unrelated donor bone marrow transplants (UD-BMT): risk factors, prophylaxis, therapy and outcome

Abstract: Summary:Gram-negative infection is an important cause of morbidity and mortality after unrelated donor-bone marrow transplantation (UD-BMT). We performed a retrospective case-control study to examine the risk factors, prophylaxis, therapy and outcome of Gram-negative bacteraemia (GNB) in 428 patients undergoing UD-BMT. The incidence of GNB was 3.6% in children and 19% in adults. Of the adults, 11% developed GNB 460 days post UD-BMT. Predisposing risk factors for GNB included 'high-risk' disease status, chronic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

8
35
4
1

Year Published

2006
2006
2024
2024

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 43 publications
(48 citation statements)
references
References 22 publications
8
35
4
1
Order By: Relevance
“…General trends in contemporary studies include an overall decreased incidence of BSI compared to earlier studies. 22,36,37 While the overall incidence of BSI by gram negative bacteria has decreased, the proportion of BSI caused by fluoroquinolone-resistant bacteria has increased compared with prior studies (Table 1). Similarly, contemporary microbial epidemiology data in pediatric HCT over the last 5 years demonstrates a decrease in CLABSI rates with a suggestive trend toward less predominance of gram positive bacteria and selection of multidrug resistant (MDR) pathogens (Table 2).…”
Section: Emerging Resistance In Bloodstream Infection Pathogens In Thmentioning
confidence: 63%
See 1 more Smart Citation
“…General trends in contemporary studies include an overall decreased incidence of BSI compared to earlier studies. 22,36,37 While the overall incidence of BSI by gram negative bacteria has decreased, the proportion of BSI caused by fluoroquinolone-resistant bacteria has increased compared with prior studies (Table 1). Similarly, contemporary microbial epidemiology data in pediatric HCT over the last 5 years demonstrates a decrease in CLABSI rates with a suggestive trend toward less predominance of gram positive bacteria and selection of multidrug resistant (MDR) pathogens (Table 2).…”
Section: Emerging Resistance In Bloodstream Infection Pathogens In Thmentioning
confidence: 63%
“…Risk factors for BSI include age greater than 18 years, use of unrelated graft source and myeloablative conditioning regimen, acute GvHD, mucositis, transplant-associated thrombotic microangiopathy (TA-TMA), high-risk malignant disease and steroid use 5,22 (Figure 2). …”
Section: Risk Factorsmentioning
confidence: 99%
“…These include age greater than 18 years, underlying disease, late stage of underlying disease, the presence of a Hickman catheter infection, severe graft-versus-host disease (GVHD), mucositis and steroid use. 4,10,[15][16][17][18][19] However, not all studies are in agreement.…”
Section: Introductionmentioning
confidence: 71%
“…Both acute and chronic GVHD are known risk factors for BSI in allogeneic transplant recipients. 6,9,23 GVHD may cause profound immunodeficiency with B-and T-cell depletion, impairment of lymphocyte function and neutropenia. 24 Patients with GHVD have also been found to have suboptimal serum opsonizing activity due to the associated hypogammaglobulinemia.…”
Section: Discussionmentioning
confidence: 99%
“…Nevertheless, the differences between infections occurring pre-and post-engraftment have not been fully described. 2,6 Most published articles regarding BSI in HSCT recipients are retrospective and/or focus on subjects who underwent transplantation in the 1990 s. 3,[5][6][7][8][9][10] Since then, there have been changes in the care of HSCT recipients, such as the introduction of different types of donors, different immunosuppression, conditioning chemotherapy including reduced-intensity regimens, and so on. Furthermore, changes in the etiology of BSI in cancer patients have recently been described.…”
Section: Introductionmentioning
confidence: 99%